As a science-based and patient-oriented healthcare company, we strive to be a global leader in growing areas of healthcare. Following a corporate transformation Novartis globally is focused on three divisions with global scale and innovation power – pharmaceuticals, eye care and generic medicines. This has strengthened the future growth prospects of the company.
In India, the Pharmaceutical business of Novartis India Limited is focused on Bone & Pain, Calcium portfolio, Gynecology and Neurosciences and the Generics business is focused on Gynecology, Anti-TB and Anti-infectives.
Pharmaceuticals develops innovative, patent-protected medicines to enhance health outcomes for patients and health-care providers. The division is at the forefront of development and commercialization in oncology, primary care and specialty medicines.
Sandoz is a global leader in the rapidly growing generics industry. Its products – which are focused in Retail Generics, Biopharmaceuticals & Oncology Injectables, and Anti-Infectives – help make affordable, high-quality medicines available to more people.